Scrip’s Five Must-Know Things – 13 November 2023

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: US approval for Lilly’s obesity drug; a look at the future of the obesity market; BMS’s ADC deal; Roche’s MS plans; and one Chinese firm’s CAR-T plans. https://scrip.citeline.com/SC149349/Quick-Listen-Scrips-Five-MustKnow-Things